Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.

Inclusion Criteria:

• • Women with suspicious breast mass (BIRADS 4a)

  • High risk women (Positive family history)
  • Women with suspicious axillary lymph nodes by Ultrasound
  • Women with dense breasts coming for MRI imaging.

Exclusion Criteria:

• • Contraindications to MRI

  • Pacemaker, cochlear implant, claustrophobia, ocular implants
  • Contraindications to contrast administration:
  • Elevated kidney functions
  • Women who haven't undergone reliable Mammogram & Ultrasound
  • Women with prior treatment or intervention (e.g. biopsy)
  • Patients' refusal.